Cancer Cachexia

Externally-Led Patient-Focused Drug Development Meeting 

A man wearing glasses works on his laptop.
cancer cachexia report cover

Voice of the Patient Report

Patients and caregivers shared their perspectives on cancer cachexia during our Externally-Led Patient-Focused Drug Development Meeting and in the 30-day period after the meeting.

Read the Report
On November 2, 2021, the Cancer Support Community held a virtual meeting to raise awareness about the impact of cancer cachexia. Cancer cachexia is a condition that causes weakness, muscle loss, and drastic unintentional weight loss leading up to a cancer diagnosis or during treatment. This meeting was focused on listening to and learning from patient and caregiver perspectives on living with cancer cachexia.
Duration: 322 min

Externally-Led Patient-Focused Drug Development Meeting on Cancer Cachexia

Join us for a virtual meeting to raise awareness of the impact of cancer cachexia – a condition that causes weakness, muscle loss, and drastic unintentional weight loss leading up to a cancer diagnosis or during treatment. This meeting will inform…

There are urgent needs in cachexia. This includes expanding education among patients, caregivers, and providers about the importance of cachexia; [and] increasing evidence, resources, and insurance coverage for supportive medical nutrition and physical therapy.

Dr. Jose Garcia MD, PhD

A term that I had never heard, cachexia, had taken control of my life. I wish there was someone on my medical team that knew about cachexia, that then they could create a patient plan to help me fight it. And it would have relieved myself and my caregivers of unnecessary disease-related stress.

Felicia Cancer Survivor

What Are Externally-Led Patient-Focused Drug Development Meetings?

EL-PFDD meetings give the Food and Drug Administration (FDA) and other key stakeholders  including medical product developers, health care providers, and federal partners  an important opportunity to hear directly from patients, their families, caregivers, and patient advocates about the symptoms that matter most to them, the impact the disease has on patients’ daily lives, and patients’ experiences with currently available treatments. This input can inform FDA’s decisions and oversight both during drug development and during their review of a marketing application for a new drug.

A woman talks with a registered dietitian in her office

Learn More About Cancer Cachexia

Our blog explains cancer cachexia, its signs and symptoms, and how to get help from your health care team.

Read Now

Supporters

Meeting Partners